Frontier Capital Management’s PTC Therapeutics PTCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q1
Sell
-103,229
Closed -$6.3M 295
2020
Q4
$6.3M Sell
103,229
-26,319
-20% -$1.61M 0.05% 251
2020
Q3
$6.06M Sell
129,548
-76,261
-37% -$3.56M 0.05% 249
2020
Q2
$10.4M Buy
205,809
+184,265
+855% +$9.35M 0.09% 217
2020
Q1
$961K Sell
21,544
-57,731
-73% -$2.58M 0.01% 268
2019
Q4
$3.81M Buy
79,275
+35,481
+81% +$1.7M 0.03% 258
2019
Q3
$1.48M Sell
43,794
-96,794
-69% -$3.27M 0.01% 275
2019
Q2
$6.33M Sell
140,588
-229,595
-62% -$10.3M 0.05% 251
2019
Q1
$13.9M Buy
370,183
+191,004
+107% +$7.19M 0.1% 214
2018
Q4
$6.15M Sell
179,179
-324,838
-64% -$11.1M 0.05% 257
2018
Q3
$23.7M Buy
504,017
+447,735
+796% +$21M 0.15% 182
2018
Q2
$1.9M Sell
56,282
-583,999
-91% -$19.7M 0.01% 287
2018
Q1
$17.3M Buy
640,281
+535,076
+509% +$14.5M 0.13% 203
2017
Q4
$1.76M Sell
105,205
-142,044
-57% -$2.37M 0.01% 278
2017
Q3
$4.95M Sell
247,249
-1,064,509
-81% -$21.3M 0.04% 264
2017
Q2
$24M Sell
1,311,758
-19,682
-1% -$361K 0.18% 172
2017
Q1
$13.1M Sell
1,331,440
-38,297
-3% -$377K 0.1% 223
2016
Q4
$14.9M Buy
1,369,737
+196,359
+17% +$2.14M 0.11% 212
2016
Q3
$16.4M Sell
1,173,378
-260,597
-18% -$3.65M 0.13% 206
2016
Q2
$10.1M Buy
1,433,975
+466,608
+48% +$3.28M 0.08% 237
2016
Q1
$6.23M Buy
967,367
+715,383
+284% +$4.61M 0.05% 261
2015
Q4
$8.16M Sell
251,984
-183,060
-42% -$5.93M 0.07% 262
2015
Q3
$11.6M Sell
435,044
-183,681
-30% -$4.9M 0.1% 241
2015
Q2
$29.8M Buy
+618,725
New +$29.8M 0.21% 164